Gulf Coast TX
AbbVie blood cancer drug combo cuts risk of progression or death in late-stage study
Oct 5 (Reuters) -- Danish biotech firm Genmab and US drugmaker AbbVie said on Monday their combination treatment for patients newly diagnosed with a type of lymphoma reduced the ri…
